Strategic Partnerships Flownamics has a history of partnering with major industry players like Beckman Coulter and RedShift BioAnalytics to expand its automation and bioprocess monitoring capabilities. This presents a sales opportunity to position complementary integration or co-sell options with potential partners and systems integrators serving bioprocess labs and production facilities.

Single-Use Innovation Recent launch of the SteriGard Single-Use Aseptic Sampling Probe indicates a move toward disposable, aseptic sampling solutions. Sales opportunities exist to target bioprocess facilities seeking reduced cross-contamination risk, lower cleaning validation burden, and faster line changes across labs, pilot plants, and manufacturing environments.

Automation Focus Flownamics specializes in automated bioreactor sampling and online monitoring solutions. There is a clear opportunity to upsell additional automation modules, control software, and integration with existing LIMS and analytics platforms to enhance productivity and data quality for bioprocess development teams.

Mid-Market Target With 11-50 employees and revenue in the 1M–10M range, Flownamics sits in a mid-market segment where scalable, easy-to-implement automation solutions are valued. Potential buyers include mid-sized biotech labs, contract development and manufacturing organizations (CDMOs), and pilot facilities seeking rapid ROI.

Global Reach & Support Historical press coverage of international partnerships (Beckman Coulter in multiple regions) and a mission focused on customized solutions suggest opportunities to emphasize global service, localized support, and training packages to multinational customers deploying bioprocess automation across sites.